Günther Claudia, Buchen Barbara, Neurath Markus F, Becker Christoph
Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany.
Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany.
Semin Cell Dev Biol. 2014 Nov;35:40-50. doi: 10.1016/j.semcdb.2014.06.004. Epub 2014 Jun 26.
Cell death in the intestinal epithelium has to be tightly controlled. Excessive or misplaced epithelial cell death can result in barrier dysfunction and, as a consequence thereof, uncontrolled translocation of components of the microbial flora from the lumen into the bowel wall. Susceptibility to gastrointestinal infections or chronic inflammation of the gut, as observed in patients with inflammatory bowel disease, can be the result of such dysregulation. Conversely, defects in cell death initiation might lead to an irregular accumulation of epithelial cells and cause intestinal cancer development. Until recently, activation of caspases in the intestinal epithelium was considered as a potential contributor to barrier dysfunction and as a pathogenic factor in the development of intestinal inflammation. Thus blocking of caspases appeared to be a potential therapeutic option for patients with inflammatory bowel disease. Recent studies on necroptosis however demonstrated that also inhibition of caspases can cause barrier dysfunction and intestinal inflammation. Caspase-8 on top of its functions in the extrinsic apoptosis pathway also controls necroptosis and turns out to be an essential molecule in regulating tissue homeostasis in the gut. Epithelial caspase-8 therefore emerges as a checkpoint not only of cell survival and cell death, but also as a regulator of the mode of cell death. According to this model, both excessive activity as well as a lack of activity of caspase-8 results in epithelial cell death and intestinal inflammation and caspase-8 needs to be tightly controlled to warrant tissue homeostasis in the gut.
肠道上皮细胞的死亡必须受到严格控制。上皮细胞过度死亡或位置异常会导致屏障功能障碍,进而导致微生物菌群的成分从肠腔不受控制地转移到肠壁。正如炎症性肠病患者所观察到的,对胃肠道感染或肠道慢性炎症的易感性可能就是这种调节失调的结果。相反,细胞死亡起始缺陷可能导致上皮细胞异常积聚并引发肠道癌症。直到最近,肠道上皮细胞中半胱天冬酶的激活还被认为是屏障功能障碍的一个潜在因素以及肠道炎症发展的致病因素。因此,对半胱天冬酶的阻断似乎是炎症性肠病患者的一种潜在治疗选择。然而,最近关于坏死性凋亡的研究表明,对半胱天冬酶的抑制也会导致屏障功能障碍和肠道炎症。半胱天冬酶 -8 除了在细胞外凋亡途径中的功能外,还控制坏死性凋亡,并且是调节肠道组织稳态的关键分子。因此,上皮半胱天冬酶 -8 不仅作为细胞存活和细胞死亡的检查点出现,而且作为细胞死亡方式的调节因子出现。根据这个模型,半胱天冬酶 -8 的过度活性以及活性缺乏都会导致上皮细胞死亡和肠道炎症,并且半胱天冬酶 -8 需要受到严格控制以确保肠道组织的稳态。